Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Zhongjie Chaorun
- ·The full record, as it builds
Funding rounds
No funding rounds for Zhongjie Chaorun are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zhongjie Chaorun
Developer of medical device products intended to support the full-cycle treatment of meniscus injuries through suture, repair, and replacement. The company offers implantable devices centered on artificial meniscus technology, developed from academic research and refined over years of clinical focus, enabling orthopedic specialists to deliver comprehensive care for patients with meniscal damage.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2020
- Ownership
- Privately Held (backing)
Zhongjie Chaorun doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zhongjie Chaorun shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zhongjie Chaorun in its N-PORT filings yet. We sweep new filings monthly.